Influences on screening for chronic diabetes complications in type 1 diabetes

Disease Management : DM
Rashida R DorseyTrevor J Orchard

Abstract

Screening for the long-term complications of diabetes is a critical component of diabetes management; however, evidence demonstrates that screening rates in diabetes populations are suboptimal. Our objective was to determine the use and predictors of optimal screening behavior, defined as receiving a fasting lipid test, dilated eye exam, spot urine test, foot examination, blood pressure reading, and hemoglobin A1c (HbA1c) in the previous year in a representative cohort of subjects with type 1 diabetes. Data are from the Pittsburgh Epidemiology of Diabetes Complications Study, a prospective cohort study of subjects with childhood onset type 1 diabetes. Data from 325 participants who responded to a survey during 1999-2001 were included in analyses. Reported screening rates were as follows: 87.9% had at least one HbA1c measurement in the past year, 63% had a foot exam, 73.3% had a spot urine test, 81.9% had a dilated eye exam, 93.5% had a blood pressure reading and 68.7% received a fasting lipid profile. Within this group, 37.7% of subjects reported undergoing all five tests (optimal screening). Independent correlates of optimal screening were receiving care from a specialist provider (odds ratio [OR] = 2.4; 95% confidence interva...Continue Reading

References

Nov 24, 1999·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·J B FowlesL Arrichiello
Jun 24, 2000·American Journal of Preventive Medicine·R E Glasgow, L A Strycker
Jun 14, 2001·Archives of Internal Medicine·S B LaditkaJ N Laditka
Sep 25, 2001·American Journal of Preventive Medicine·E W GreggM M Engelgau
Dec 1, 2001·Endocrinology and Metabolism Clinics of North America·J S Skyler
Apr 17, 2002·Annals of Internal Medicine·Jinan B SaaddineK M Venkat Narayan
Aug 28, 2002·Diabetes Care·Sheldon Greenfield
Sep 27, 2002·Diabetes/metabolism Research and Reviews·Jay S Skyler, Carolyn Oddo
Dec 11, 2002·Journal of Advanced Nursing·Katarina HjelmJan Apelqvist
Mar 1, 2003·Diabetes Care·Paul HoganUNKNOWN American Diabetes Association
Jul 2, 2003·Diabetes Care·UNKNOWN American Diabetes Association

❮ Previous
Next ❯

Citations

Jun 24, 2014·Primary Care Diabetes·Maja RačićDjordje Božović

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.